Unknown EARLY_PHASE1 INTERVENTIONAL 1-arm NCT05638828

A Study of RD14-01 in Patients With Advanced Solid Tumors

Sponsor: Shen Lin

Updated 4 times since 2023 Last updated: Nov 28, 2022 Started: Dec 1, 2022 Primary completion: Dec 1, 2023 Completion: Dec 1, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A EARLY_PHASE1 clinical study on Solid Tumor, this trial is ongoing. The trial is conducted by Shen Lin and has accumulated 4 data snapshots since 2022. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

4 versions recorded

Jan 2025 — Present [monthly]

Unknown EARLY_PHASE1

Status: Not Yet Recruiting → Unknown
Sep 2024 — Jan 2025 [monthly]

Not Yet Recruiting EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting EARLY_PHASE1
Jan 2023 — Jul 2024 [monthly]

Not Yet Recruiting EARLY_PHASE1

First recorded

Dec 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shen Lin

Data source: Peking University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.